3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
4
Active not recruiting
3
Withdrawn
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Cyclophosphamide
10
fludarabine
9
Radiotherapy
9
Biopsy
8
atezolizumab
7
Nivolumab
7
Radiation
6
Prednisone
4
Gemcitabine
4
Etoposide
4
Cytarabine
4
Cisplatin
4
Carboplatin
4
Blood Specimen Collection
4
ALT-803
4
lenvatinib
3
fludarabine phosphate
3
avelumab
3
aldesleukin
3
X-Rays
3
Vincristine
3
Surveys and Questionnaires
3
Rituximab
3
Phantoms, Imaging
3
Paclitaxel
3
Oxaliplatin
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
monalizumab
×
1 year
×
Clear all
NCT06152523
2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2
Withdrawn